StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp (EW) stock

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$107.15+1.35 (+1.28%)

Close on Nov 13, 2026Market cap $61.76BP/E 60.5Yield –

Edwards Lifesciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Edwards Lifesciences's price to sales ratio was 9.4× on Nov 11, 2026, against 8.6× a year earlier. Over the last 5 years it ranged from 7.4× to 15.9×, with a median of 8.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.4×+1.0
2025Dec 31, 20258.4×+0.2
2024Dec 31, 20248.2×−2.9
2023Dec 29, 202311.1×+2.5
2022Dec 30, 20228.6×−7.3
2021Dec 31, 202115.9×+2.9
2020Dec 31, 202013.0×+1.3
2019Dec 31, 201911.7×+2.9
2018Dec 31, 20188.8×+1.6
2017Dec 29, 20177.2×+0.2
2016Dec 30, 20167.0×+0.0
2015Dec 31, 20157.0×+0.9
2014Dec 31, 20146.1×+2.5
2013Dec 31, 20133.6×−2.2
2012Dec 31, 20125.7×+0.8
2011Dec 30, 20114.9×−1.7
2010Dec 31, 20106.6×+2.4
2009Dec 31, 20094.2×–

More Edwards Lifesciences figures

See a number that looks wrong?